Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05213806Not ApplicableRecruiting

WithHolding Enteral Feeds Around Blood Transfusion (International)

Role: collaborator

NCT06689501Not ApplicableCompleted

12-Week Trial Investigating L-carnitine Tartrate, Dihydrocapsiate and Protein Yeast Hydrolysate on Energy Intake and Expenditure in Overweight Adults

Role: collaborator

NCT04400656Completed

PROState Pathway Embedded Comparative Trial

Role: collaborator

NCT04049747Not ApplicableCompleted

Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer

Role: collaborator

All 4 trials loaded